Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management

British Journal of Ophthalmology

Volumn 81, Issue 3, 1997, Pages 228-233

  Boulton, Mike ^a,c   Gregor, Zdenek ^b   McLeod, David ^a   Charteris, David ^a   Jarvis Evans, John ^a   Moriarty, Patrick ^a   Khaliq, Asud ^a   Foreman, David ^a   Allamby, David ^a   Bardsley, Bill ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GLUCOSE; GROWTH FACTOR; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS; VITRECTOMY; VITREOUS BODY;

EID: 0030893294     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.81.3.228     Document Type: Article

References (34)

1. Boulton M, McLeod D, Garner A. Vasoproliferative retinopathies: clinical morphogenetic and modulatory aspects. Eye 1988;2:S124-39.
2. Battegay E. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995;73: 333-46.
3. Sharp P. The role of growth factors in the development of diabetic retinopathy. Metabolism 1995;44:72-5.
4. Boulton M, Foreman D, McLeod D. Vascularised vitreoretinopathy: the role of growth factors. Eye 1996; (in press).
5. Baird A, Culler F, Jones K. Angiogenic factor in human ocular fluid. Lancet 1985;2:563.
6. Sivalingham A, Kenney J, Brown G, Benson W, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy Arch Ophthalmol 1990;108:869-72.
7. Grant M, Russel B, Fitzgerald C, Merimee T. Insulin-like growth factor in the vitreous. Diabetes 1986;35:53-64.
8. Meyer-Schwickerath R, Pfeiffer A, Blum W, Freyberger H, Klein M, Losche C, et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease: studies in non-diabetic and diabetic subjects. J Clin Invest 1993;92:2620-5.
9. Waldbillig R, Jones B, Schoen T, Moshayedi P, Heidersbach S, Bitar M, et al. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics. Curr Eye Res 1994;13:539-46.
10. Asrar A, Maimone D, Morse P, Gregory S, Reder A. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 1992;114:731-6.
11. Tang S, Scheiffarth O, Thurau S, Wildner G. Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferaave diabetic retinopathy. Ophthalmic Res 1993;25:177-85.
12. Aiello L, Avery R, Arigg P, Keyt B, Jampel H, Shah S, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
13. Adamis A, Miller J, Bernai M, D'Amico D, Folkman J, Yeo T, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmul 1994;118:445-50.
14. Taylor C, Kissun R, Schor A, McLeod D, Garner A, Weiss J. Endothelial cell-stimulating angipgenesis factor in vitreous from extraretinal neovascularisations. Invest Ophthalmol Vis Sci 1989;30:2174-8.
15. Klagsbrun M, D'Amore P. Regulators of angiogenesis. Annu Rev Physiol 1991;53:217-39.
16. Shultz G, Grant M. Neovascular growth factors. Eye 1991; 5:170-80.
17. Boulton M, Moriarty P, Gregor Z. Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes. Br J Ophthalmol 1992;76: 79-83.
18. Khaliq A, Patel B, Jarvis-Evans J, Moriarty P, McLeod D, Boulton M. Oxygen modulates production of bFGF and TGF-β by retinal cells in vitro. Exp Eye Res 1995;60:415-24.
19. Moriarty P, Boulton M, Dickson A, McLeod D. Production of IGF-I and IGF binding proteins by retinal cells in vitro. Br J Ophthalmol 1994;78:638-42.
20. Hossenlopp P, Seurin D, Segovia-Quinson B, Herdouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using western ligand blotting: use of the method for titration of binding proteins and competitive binding studies. Anal Biochem 1986;208:439-14.
21. Bland M. An introduction to medical statistics. Oxford: Oxford University Press, 1995
22. Bardsley W, Bukhari N, Ferguson M, Cachaza J, Burguillo F. Evaluation of model discrimination, parameter estimation and goodness of fit in nonlinear regression problems by test statistics distributions. Computers Chem 1995;19:75-84.
23. de Boer J, Limpens J, Orengo-Nania S, de Jong P, La Heij E, Kijlstra A. Low mature TGF-β2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci 1994;35:3702-10.
24. Conner T, Roberts A, Sporn M, Danielpour D, Dart L, Michels R, et al. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Clin Invest 1989; 83:1661-6.
25. Arnold D, Moshayedi P, Schoen T, Jomes B, Chader G, Waldbillig R. Distribution of IGF-I and -II binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous. Exp Eye Res 1993;56:555-65.
26. Patel B, Hiscott P, Charteris D, Mather J, McLeod D, Boulton M. Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. Br J Ophthalmol 1994;78:714-8.
27. Danias J, Stylianopoulou F. Expression of IGF-I and IGF-II genes in the adult rat eye. Curr Eye Res 1990;9:379-86.
28. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994;112:1476-82.
29. Boulton M, Patel B, Khaliq A, Moriarty P, Jarvis-Evans J, McLeod D. Modulators and milieu in preretinal neovascularisation. Eye 1992;6:560-5.
30. Singh A, Boulton M, Lane C, Forrester J, Gaal J, McLeod D. Inhibition of microvascular endothelial cell proliferation by vitreous following retinal scatter photocoagulation. Br J Ophthalmol 1990;74:328-32.
31. Clemmons D. IGF binding proteins and their functions. Mol Reprod Dev 1993;35:368-75.
32. Hanneken A, Baird A. Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid. Invest Ophthalmol Vis Sci 1995;36:1192-6.
33. Heath J. Growth factors. Oxford: IRL Press, 1993.
34. Sporn M, Roberts A. Peptide growth factors are multifunctional. Nature 1988;332:217-9.